Comparison of the malaria parasite and mammalian protein prenyl transferases and their cellular substrates is important for establishing this enzyme as a target for developing antimalarial agents. Nineteen heptapeptides differing only in their carboxy terminal amino acid were tested as alternative substrates of partially purified Plasmodium falciparum protein farnesyl transferase. Only NRSCAIM and NRSCAIQ serve as substrates, with NRSCAIM being the best. 
INTRODUCTION
Malaria continues to be a major disease in tropical areas of the world. Parasite resistance to current drugs used in the treatment of malaria has lead investigators to seek out new drug targets. Among those targets are proteins and enzymes, which are necessary for cellular division and differentiation. Such targets include the protein prenyl transferases, which are necessary for the post-translational modification of proteins involved in the signal transduction pathways involved in regulation of DNA replication and cell cycling (1) (2) (3) . These enzymes are currently a major focus of efforts to design drugs that inhibit unregulated cell growth in cancer (4, 5) . Several candidate compounds show great promise as anti-tumor drugs and are currently being tested in clinical trials. The potential for the application of such drugs to inhibit malarial parasite division and differentiation motivates one to examine the properties of the protozoan enzyme with the goal of identifying unique features of this enzyme which would make it a target for the development of parasite specific drugs.
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Growth and Isolation of P. falciparum P. falciparum 3D7 was grown in vitro in a modified erythrocyte culture as previously described (31, 34) . The parasite pellet was isolated from infected erythrocytes by treatment with 0.1% (w/v) saponin for 5 min followed by two washes with phosphate-buffered saline, pH 7.2 at 1,800 x g for 7 min. When needed, cultures were synchronized with 5% sorbitol (35) . Typically parasites were harvested, postsynchronization, at 6 h for rings, 20 h for trophozoites and 32 h for schizonts. The yield was about 4-5 x 10 7 parasites ml -1 of culture. The growth of parasites was monitored by light microscopy of Leukostat (Fisher) stained thin smears. Pellets of parasites were stored at -80 o C.
They were stable in this form for at least 6 months.
Partial Purification of Protein Farnesyl Transferase Conceptual translation of two
open reading frames, chr12_1.glm_484 and chr11_1.glm_536, obtained from the malaria genome database (http://www.plasmodb.org) yields protein sequences that undoubtedly describe the α and β subunits, respectively, of PfPFT. However, multiple attempts to express PfPFT in Escherichia coli as a translationally coupled heterodimer have not been successful to date. In the absence of recombinant enzyme, native PfPFT, which was partially purified by ammonium sulfate fractionation or Mono-Q chromatography, has been used for in vitro assays. Parasite pellets from 1 liter of cultures (100 plates at 10-20% parasitemia, predominantly trophozoites)
were homogenized at 4°C and the cell suspension sonicated to disrupt the cells as previously described (31) . The lysate was centrifuged at 100,000 x g with a 50.1 Ti rotor for 1 h at 4°C and 7 partially purified by Mono-Q chromatography by modifications of previously described methods at 4°C (31, 36) . Peak fractions were pooled, concentrated by ultrafiltration and stored at -80°C. Enzyme assays using non-biotinylated peptides as substrates were incubated under the same conditions as described for the SPA, except that different non-biotinylated heptapeptides (2 µM) were substituted for the biotinylated lamin B peptide. The amount of prenylated product was quantitated after purification on 1 ml SPE anion exchange chromatography columns (J.T.
Enzyme Assays and Inhibitor Studies
Baker) (28). The first two eluted fractions were pooled and subjected to TLC on Silica G sheets in n-propanol:NH 4 OH:water (6:3:1,v/v/v). The positions of migration of the prenylated peptides were determined by cutting each lane into 1 cm sections and analyzing for radioactivity.
Prenylated peptides (1000-2000 cpm) migrated with R f 's of 0.69, which is consistent with previously reported R f 's (0.67-0.74) for this system (37 DeltaVision software (SoftWoRx) was used for image deconvolusion.
RESULTS

In vitro Inhibition of PfPFT with Peptidomimetics Our earlier studies showed that
PfPFT was poorly inhibited by the farnesyl diphosphate analogues FPT inhibitor-I and -II, whereas the peptidomimetic PFT inhibitor, L-745631, was an effective inhibitor with an IC 50 of 3-4 nM (31). Several additional peptidomimetics (Table I) were tested here with Mono Qpurified PfPFT. PFT inhibitor, FTI-276, and geranylgeranyl transferase inhibitors, GGTI-287
and GGTI-297 each inhibit at concentrations comparable to those reported for the mammalian PFTs (Table II) . FTI-276 shows the best inhibition and is slightly more inhibitory than L- (Fig 2, lanes A1, B1) also suggests no contribution from prenylation of erythrocytic proteins.
2D Separation of Proteins Labeled with Prenyl Groups During Malaria Parasite
Intraerythrocytic Differentiation Proteins radiolabeled with [geranylgeraniol during P. falciparum differentiation in erythrocytes were also separated by twodimensional electrophoresis. Multiple labeled proteins are observed in both the 50 kDa and 22-28 kDa range when using [ 3 H]-farnesol (Fig. 3) . Proteins in the 50 kDa range are found predominately in the trophozoite stage (Fig. 3B (also see Fig. 2A lane 2) and they appear to be of the same molecular weight but different charge. Multiple proteins are found in the 22-28 kDa range of cells in both the trophozoite (Fig. 3B) and schizont (Fig. 3C) (Fig. 5, panel 3) . Similar vacuoles are not observed in control cells (Fig. 5, panel 2) .
Furthermore, the inhibitor treated cells do not mature beyond the trophozoite stage and the few parasites that escape inhibition at the IC 50 inhibitor concentration mature normally but are arrested at the trophozoite stage in the next developmental cycle (data not shown).
Changes in the Intracellular Localization of Prenylated Proteins Following Treatment
with Peptidomimetics To analyze the localization of prenylated proteins in P. falciparum, a commercially available rabbit farnesyl polyclonal antibody was used in an indirect immunofluorescence experiment. This antibody was generated using farnesyl cysteine conjugated to keyhole limpet hemocyanin and cross-reacts also with geranylgeranylated proteins.
Prenylated proteins exhibit distinct foci of localization and are detected in all stages of intraerythrocytic maturation ( (54), also suggests that compartmentalization of prenol metabolism and protein prenylation may be a possibility. This is particularly evident when noting that radiolabeling of the proteins in the 22-28 kDa range was inhibited by the prenyl transferase inhibitors that are specific for PFT and PGGT-I and not the Rab PGGT (42) . Therefore, although Rab proteins have been described in P. falciparum (56) , the labeled 22-28 kDa proteins are apparently not those Rabs. The ability of PFT inhibitors to inhibit geranylgeranylation at low micromolar concentrations is also not readily explainable. We have reported the presence of PGGT-I in P. falciparum (31), but our inability to isolate a stable PGGT-I activity from P.
Inhibition of in vivo Radiolabeling of P. falciparum Prenylated Proteins with
falciparum extracts has prevented a determination of the sensitivity of PGGT-I to PFT and PGGT-I inhibitors.
Prenylated proteins labeled with [ 3 H]-farnesol are observed in both the 50 kDa and 22-28 kDa ranges during the trophozoite to schizont and schizont to ring stages of differentiation, whereas few prenylated proteins are observed in the ring to trophozoite stage. Our previous studies (31) demonstrated PFT and PGGT-I activity in each of these stages, therefore this suggests that the marked decrease in protein prenylation during the ring to trophozoite transition is due to a decrease in the production of suitable protein substrates for prenylation. It is noteworthy that peptidomimetic L-745,631, a PFT inhibitor, had no effect on the transition of schizont to early trophozoite (31) . We have also shown here that another PFT inhibitor, FTI-277, blocks maturation of the parasite during the trophozoite stage. The appearance of distinctive prenylated proteins during specific stages of P. falciparum differentiation is a novel observation for parasites. Therefore, it is of considerable interest to understand the role of prenylated proteins in cell cycle progression in malaria. Proteins in the 50 kDa range are found predominately in the trophozoite stage and appear to be of the same molecular weight but different charge as assessed by 2D electrophoretic analysis. The migratory differences could be attributed to differences in phosphorylation or glycosylation.
Phosphorylation seems more likely because there is little difference in the molecular weights of these proteins. Earlier studies on protein prenylation in murine lymphoma cells (61) and in rat seminiferous epithelium (40) also described multiple prenylated proteins of the same molecular weight that appeared to be phosphorylated. Prenylated proteins of different charge and molecular weight were also observed in the 22-28 kDa range from parasites at both the trophozoite and schizont stages. Although several proteins appear to be common to the two stages judging from their position of migration, there is differential labeling with some and at least one protein is labeled specifically at the schizont stage.
The specificity of PfPFT for the amino acid at the carboxyl terminus is similar to the mammalian PFT (13, 14, 62) in that peptides ending in methionine and glutamine are substrates but is different in that peptides ending in serine, threonine and cysteine are not substrates. 
